Effect of montelukast combined with budesonide formoterol treatment for acute bronchial asthma
10.3760/cma.j.issn.1008-6706.2017.11.021
- VernacularTitle:孟鲁司特钠联合布地奈德福莫特罗治疗支气管哮喘急性发作的效果研究
- Author:
Qin XU
- Keywords:
Asthma;
Montelukast;
Budesonide formoterol
- From:
Chinese Journal of Primary Medicine and Pharmacy
2017;24(11):1677-1680
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of montelukast combined with budesonide for treating acute bronchial asthma, pulmonary function improvement and to provide the basis for clinical treatment.Methods 192 patients with acute asthma were selected.They were divided into the control group and the observation group according to the admission order and odd and even numbers randomly, 96 patients in each group.The control group was treated with budesonide based on routine treatment, and the observation group was given budesonide formoterol based on the control group.The clinical effect, pulmonary function (forced expiratory volume in one second (FEV1),FEV1/forced vital capacity (FVC) and peak expiratory flow (PEF) the percentage of predicted value index percentage were observed.The daytime and night asthma symptoms and airway reactivity score: early respiratory resistance (Rrsc) and response threshold (Dmin) were assessed.Results The cough disappeared, shortness of breath, wheezing relieving, moist rales disappeared and wheeze disappeared time of the observation group after treatment were (5.92±1.03)d,(3.48±0.71)d,(3.74±0.69)d,(5.32±0.96)d and (5.12±0.77)d, which were lower than those of the control group (t=9.31,7.26,8.11,9.02,8.31,all P<0.05).The daytime and nighttime asthma symptom scores of the observation group after treatment were (0.54±0.31)points and (0.62±0.29)points, which were lower than those of the control group (t=7.90,7.33,all P<0.05).Rrsc score of the observation group after treatment was (2.20±0.56)points, which was lower than that of the control group (t=7.86,P<0.05).The Dmin score of the observation group after treatment was (8.33±0.81)points, which was higher than that of the control group (t=9.15,P<0.05).FEV1,FEV1/FVC and PEF of the two groups after treatment were significantly higher than those before treatment(all P<0.05).FEV1,FEV1/FVC and PEF of the observation group after treatment were (2.95±0.58)L,(71.91±0.69) and (96.45±6.11), which were higher than those of the control group after treatment (t=7.60,9.45,10.21,all P<0.05).Conclusion Montelukast combined with budesonide formoterol in the treatment of acute attack of bronchial asthma has better effect, could significantly reduce the symptoms of asthma patients and shorten the treatment time with synergistic effect, and improve the pulmonary ventilation function of the patients.
